Third Harmonic Bio

Developer therapeutics to treat allergy and inflammatory diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2019 groups28 employees language thirdharmonicbio.com

Registered entities

Innovation

7 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 161 times.

YearFilings
20223
20232
20243
20255

Investor mix

10 investors on record; lead investors include Atlas Venture, BVF Partners, Orbimed, General Atlantic.

Investor typeCountShare
Venture capital550%
Private equity220%
Other / undisclosed330%
Coming soon